Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Κατάταξη σε μετοχές #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Τιμή μετοχής
$25.28
Τελευταίος συγχρονισμός: 2026-09-18
Κεφαλαιοποίηση
$1.01B
Αλλαγή (1 ημέρα)
-2.29%
Αλλαγή (1 έτος)
-37.84%
Χώρα
GB
Εμπόριο GSK plc (GSK)

Κατηγορία

Κέρδη για την GSK plc (GSK)
Κέρδη τον Jun 2026 TTM: $8.03B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της GSK plc, τα τρέχοντα κέρδη της εταιρείας είναι $8.03B. Το 2024, η εταιρεία παρουσίασε κέρδη $4.36B, μείωση σε σύγκριση με των κερδών του 2023 που ήταν $7.72B. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την GSK plc από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
Έτος Κέρδη Αλλαγή
2026 (TTM) $8.03B -17.47%
2025 $9.73B 123.11%
2024 $4.36B -43.48%
2023 $7.72B 13.38%
2022 $6.81B 39.93%
2021 $4.87B -31.16%
2020 $7.07B -14.32%
2019 $8.25B 34.93%
2018 $6.11B 28.34%
2017 $4.76B 99.06%
2016 $2.39B -84.57%
2015 $15.51B 235.45%
2014 $4.62B -58.00%
2013 $11.01B 2.83%
2012 $10.71B -10.38%
2011 $11.95B 143.12%
2010 $4.91B -61.53%
2009 $12.77B 31.37%
2008 $9.72B -35.26%
2007 $15.02B -1.77%
2006 $15.29B 31.99%
2005 $11.58B 4.33%
2004 $11.10B -1.73%
2003 $11.30B 27.36%
2002 $8.87B 0.26%
2001 $8.85B -1.72%
2000 $9.00B 0.00%
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
Εταιρεία Κέρδη Διαφορά Κερδών Χώρα
$33.59B 318.17%
US
$25.20B 213.63%
US
$8.70B 8.28%
US
$21.39B 166.24%
CH
$5.95B -25.96%
US